A pharmaceutical company built around two lines and four markets.

---

Our story

Oxalas began with a simple observation: in the markets we know best, the gap between a good medicine and the patient who needs it is rarely the science. It is everything around it — registration that takes years, supply that breaks at the last mile, leaflets written for regulators rather than people, and supplements sold on promises their labels cannot keep.

We set out to build a company that does that unglamorous work properly. Not a laboratory, and not a trading house — a pharmaceutical company whose craft is taking proven medicines and trustworthy nutrition products through each country’s regulatory pathway, into licensed pharmacies, and into people’s hands with information they can actually use.

We chose two lines deliberately. Prescription and over-the-counter medicines demand rigour: dossiers, pharmacovigilance, the discipline of doing things the regulator’s way. Vitamins and supplements demand honesty: the temptation in that category is to claim more than the evidence supports, and we decided early that our labels would say exactly what is in the pack, at the stated amount, and nothing more.

We chose four markets deliberately too. Egypt, Saudi Arabia and the United Arab Emirates are where our roots and our partners are — among the region’s largest and fastest-growing healthcare markets, each with its own authority, language needs and pharmacy culture. The United States holds us to one of the most demanding regulatory standards in the world, and working there keeps the bar high everywhere else. A leaflet in Cairo should be as clear and as current as one in Riyadh, Dubai or Chicago.

The name and the mark carry the idea. The facets of the Oxalas star are separate pieces that only make a shape together — the way regulatory work, manufacturing, distribution, pharmacies and prescribers only make a trustworthy medicine when each piece is done well and fits the next. That is the company we are building: focused, patient, and held to one standard in every market we serve.

---

Who we are

Oxalas is a privately held pharmaceutical company. We do not try to do everything. We focus on two product lines — prescription and over-the-counter medicines, and vitamins and supplements — and on doing the work that makes them trustworthy: registration with the health authority, qualified manufacturing, controlled distribution, accurate labelling and active pharmacovigilance.

Because we operate in both regulated Western and Middle Eastern markets, one standard of quality and information applies everywhere. A leaflet in Cairo says the same thing as a leaflet in Riyadh or Chicago, in the language of the patient reading it.

---

Where we are

We operate in four markets and treat each as a home market, with local regulatory work, local partners and local safety reporting: the United States, Saudi Arabia, the United Arab Emirates and Egypt.